Author's posts
Trump administration could leverage waivers for state CON law repeals
Hospitals that want their states to keep up their certificate-of-need laws are on the alert after last week’s sweeping health policy directive from the White House shows shifting ground.
Partners reports nearly six-fold jump in operating income
Partners HealthCare grew its operating income significantly from fiscal 2017 to fiscal 2018, which ended Sept. 30.
CMS finalizes plan to continue risk-adjustment program for 2018
The CMS issued a final rule that allows the agency to continue the normal operations of the Affordable Care Act risk-adjustment program for 2018.
U.S. organ transplant rules get an overhaul
The organ transplant community saw a transformation of the decadeslong system of allocating organs to patients based on geographic proximity.
Why one state that did everything right is still losing ACA exchange enrollment
Enrollment in New Jersey’s insurance exchange during open enrollment this year trails last year’s sign-ups by 14%. That’s despite state efforts to enact an individual mandate, implement a reinsurance program and prohibit short-term insurance plans.
University Health CEO resigns amid bacterial outbreak
Four premature babies in the neonatal ICU have contracted the Acinetobacter baumannii bacteria since September, three of whom died, according to public health officials.
Healthcare made the most U.S. hires in November
The U.S. healthcare industry made more hires than any other sector in November, according to the latest federal government jobs report.
6 doctors charged in alleged $464 million scheme to prey on addicts
Five metro Detroit doctors and one from the Grand Rapids area have been indicted for allegedly running a $464 million healthcare fraud scheme that involved millions of opioid drugs and unnecessary medical procedures in Southeastern Michigan.
Drugmaker to sell cheaper generic rival to EpiPen injectors
Generic-drug maker Sandoz will start selling an alternative to the EpiPen in the U.S. early next year. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.
Editorial: Healthcare, our biggest trade barrier
Tariff battles, whether in 1992 or 2018, will not solve what remains one of U.S. businesses’ main international competitiveness problems: the higher prices they pay for healthcare and the tab’s uneven distribution.
